Shotgun 1 #1 October 26, 2008 Apparently Palin thinks that studying fruit flies has "little or nothing to do with the public good." http://thinkprogress.org/2008/10/24/palin-fruit-flies/ Now to be fair, I believe the research she is referring to is at this lab where they study fruit flies as pests, rather than studying autism, as the other link suggests. But I still get the impression that she thinks they're studying fruit flies just for the fun of it. Quote Share this post Link to post Share on other sites
MegaGoliath11 0 #2 October 26, 2008 The whole pork barrel argument is getting old. Palin/McCain 2008 needs to come up with something else and more intelligent to say. I'm so freaking tired of hearing about the 2 million dollar projector! It was for a freaking planetarium SEN! Quote Share this post Link to post Share on other sites
Shotgun 1 #3 October 26, 2008 Quote Palin/McCain 2008 needs to come up with something else and more intelligent to say. Hey, it was very intelligent of her to laugh about fruit fly research during a speech where she's talking about helping children with disabilities. I mean, why would anyone want to study fruit flies? Quote Drosophila drug screen for fragile X syndrome finds promising compounds and potential drug targets Scientists using a new drug screening method in Drosophila (fruit flies), have identified several drugs and small molecules that reverse the features of fragile X syndrome -- a frequent form of mental retardation and one of the leading known causes of autism. The discovery sets the stage for developing new treatments for fragile X syndrome. The results of the research by lead scientist Stephen Warren, PhD, chair of the Department of Human Genetics at Emory University School of Medicine, are published online in the journal Nature Chemical Biology. Dr. Warren led an international group of scientists that discovered the FMR1 gene responsible for fragile X syndrome in 1991. Fragile X syndrome is caused by the functional loss of the fragile X mental retardation protein (FMRP). Currently there is no effective drug therapy for fragile X syndrome, and previously no assays had been developed to screen drug candidates for the disorder. During the past 17 years, intense efforts from many laboratories have uncovered the fundamental basis for fragile X syndrome. Scientists believe FMRP affects learning and memory through regulation of protein synthesis at synapses in the brain. One leading view, proposed by Dr. Warren and colleagues, suggests that over stimulation of neurons by the neurotransmitter glutamate is partly responsible for the brain dysfunction resulting from the loss of FMRP. In their current experiment, Emory scientists used a Drosophila model lacking the FMR1 gene. These fruit flies have abnormalities in brain architecture and behavior that parallel abnormalities in the human form of fragile X syndrome. When FMR1-deficient fly embryos were fed food containing increased levels of glutamate, they died during development, which is consistent with the theory that the loss of FMR1 results in excess glutamate signaling. The scientists placed the FMR1-deficient fly embryos in thousands of tiny wells containing food with glutamate. In addition, each well contained one compound from a library of 2,000 drugs and small molecules. Using this screening method, the scientists uncovered nine molecules that reversed the lethal effects of glutamate. The three top identified compounds were known activators of GABA, a neural pathway already known to inhibit the effects of glutamate. In the study, GABA reversed all the features of fragile X syndrome in the fruit flies, including deficits in the brain's primary learning center and behavioral deficits. The screening also identified other neural pathways that may have a parallel role in fragile X syndrome and could be targets for drug therapy. "Our discovery of glutamate toxicity in the Drosophila model of fragile X syndrome allowed us to develop this new screen for potential drug targets," notes Dr. Warren. "We believe this is the first chemical genetic screen for fragile X syndrome, and it highlights the general potential of Drosophila screens for drug development. "Most importantly, it identifies several small molecules that significantly reverse multiple abnormal characteristics of FMR1 deficiency. It also reveals additional pathways and relevant drug targets. These findings open the door to development of effective new therapies for fragile X syndrome." Quote Share this post Link to post Share on other sites
lawrocket 3 #4 October 26, 2008 Drolophila melanogaster is one of the most used - if the THE most used - organism in biological research - especially genetics. It does demonstrate a misunderstanding of the concept. My wife is hotter than your wife. Quote Share this post Link to post Share on other sites
kallend 2,027 #5 October 26, 2008 QuoteDrolophila melanogaster is one of the most used - if the THE most used - organism in biological research - especially genetics. It does demonstrate a misunderstanding of the concept. Why would that impress a creationist?... The only sure way to survive a canopy collision is not to have one. Quote Share this post Link to post Share on other sites
billvon 2,991 #6 October 26, 2008 >Apparently Palin thinks that studying fruit flies has "little or nothing to do >with the public good." "Deoxyribonucleic acid? I think we should be studying human genetics, not some stupid acid!" Quote Share this post Link to post Share on other sites
shropshire 0 #7 October 26, 2008 Quoteacid! sounds like she's been dropping some (.)Y(.) Chivalry is not dead; it only sleeps for want of work to do. - Jerome K Jerome Quote Share this post Link to post Share on other sites